MeCare Alpha (MCA2019)
IVT Medical, Ltd. · Decision date Oct 8, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for MeCare Alpha (MCA2019), submitted by IVT Medical, Ltd. of Ra'Anana, Israel, under 510(k) number K260426. The decision date is 2026-10-08 and the application was received 02/10/2026. The device falls under regulation 878.4780, product code OMP, classified as a Negative Pressure Wound Therapy Powered Suction Pump, with General & Plastic Surgery as the regulation medical specialty and review panel. This is a traditional 510(k) reviewed by FDA, not a third-party review, and not a combination product.
SESE means FDA found the submission substantially equivalent to a legally marketed predicate device; it is a clearance, not a PMA approval. The source record does not identify the predicate device, the specific components or changed items covered, the indications for use, or any performance data supporting the equivalence finding. The public listing also does not include the review memorandum or clearance letter, so the basis for the decision remains unknown from this data.
The record shows no predetermined change control plan authorization and no expedited review flag. Researchers should treat the scope of this clearance as limited to what the FDA database states and consult the underlying 510(k) documents for device description and labeling.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Oct 8, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260426
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- IVT Medical, Ltd.
- Product code
- OMP
- Decision code
- SESE
- Decision date
- Oct 8, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Negative Pressure Wound Therapy Powered Suction Pump.
- Applicant
- IVT Medical, Ltd.
- Product code
- OMP
- FDA device class
- 2
FDA decision timeline
K260426 received
Application receipt date recorded by FDA.
K260426 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code OMP
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Bechtel Medical, Inc. | 510(k) clearance | Nov 6, 2026 | FDA | |
| Smith & Nephew Medical, Ltd. | 510(k) clearance | Oct 30, 2026 | FDA | |
| Smith & Nephew Medical, Ltd. | 510(k) clearance | Oct 23, 2026 | FDA | |
| Smith & Nephew Medical, Ltd. | 510(k) clearance | Sep 11, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
IVT Medical, Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Ra'Anana
Sources and methodology
- Original FDA record: K260426
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

